TelyRx Holdings Inc. (TSX:TELY)
2.290
0.00 (0.00%)
Nov 9, 2026, 11:14 AM EST
TelyRx Holdings Revenue
TelyRx Holdings had revenue of $23.08M USD in the quarter ending September 30, 2026, with 87.06% growth. This brings the company's total for the last twelve months to $79.46M, up 138.64% year-over-year. In the year 2025, TelyRx Holdings had annual revenue of $42.92M with 350.27% growth. That makes TelyRx Holdings the 24,435th largest company in the world by revenue and 446th in Canada.
Revenue (ttm)
$79.46M
Revenue Growth
+138.64%
P/S Ratio
0.99
Revenue / Employee
n/a
Employees
n/a
Market Cap
111.87M CAD
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 42.92M | 33.39M | 350.27% |
| Dec 31, 2024 | 9.53M | 9.51M | 35,207.41% |
| Dec 31, 2023 | 27.00K | - | - |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. It does not take any expenses into account and is therefore different from profits.
TelyRx Holdings News
- 3 days ago - TelyRx Holdings Earnings Call Transcript: Q3 2026 - Transcripts
- 3 days ago - TelyRx Holdings MD&A: Q3 2026 - Filings
- 3 days ago - TelyRx Holdings Report: Q3 2026 - Filings
- 3 days ago - TelyRx Holdings Earnings release: Q3 2026 - Filings
- 3 days ago - TelyRx Announces Board Changes - Newsfile Corp
- 4 days ago - TelyRx Announces Third Quarter 2026 Financial Results - Newsfile Corp
- 18 days ago - TelyRx to Host Third Quarter 2026 Financial Results Conference Call on Friday, November 6, 2026 at 8:30 am ET - Newsfile Corp
- 4 weeks ago - TelyRx Expands Women's Health Offerings with New Menopause Supplement - PRNewsWire